September 13, 2011 — .decimal Inc. (pronounced dot decimal) announced it received 510(k) clearance from the  U.S. Food and Drug Administration (FDA) to market electron apertures for use with Varian treatment machines. These devices are now available to radiation oncology centers across the United States and Canada.

Electron apertures — also known as electron “cutouts” or collimators by radiation therapy departments — are medical devices required for targeted delivery of electrons to patients in radiation therapy.

An electron aperture is a metal tool implemented in cases of neck and head or breast cancer. It features an opening through which a radiation beam passes during delivery of electrons to a patient with a tumor.

Hospitals and cancer centers across the United States will order electron apertures via the Internet; they often receive the devices already in the mold frames within 24 to 72 hours from receipt of an order.

By providing custom-made electron apertures to radiation oncology centers, .decimal helps reduce the cost of maintaining an on-site mold room.

Cerrobend is an alloy composed of cadmium, lead and tin that can be shaped at relatively low temperatures. It does, however, release toxic fumes that, when produced at a medical facility, have the potential for affecting clinical personnel thus requiring expensive ventilation systems.

With this solution, .decimal provides radiation therapy facilities the ability to focus on treating patients, rather than manufacturing medical devices.

For more information: www.dotdecimal.com/products/ElectronAperture


Related Content

News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
News | Prostate Cancer

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
News | Radiology Business

July 3, 2024 — The American Society of Radiologic Technologists has launched the BeRAD Professionalism Award to ...

Time July 03, 2024
arrow
News | Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
News | Radiation Oncology

June 3, 2024 — The American Society for Radiation Oncology (ASTRO) published an updated clinical guideline that details ...

Time June 03, 2024
arrow
News | Oncology Information Management Systems (OIMS)

May 30, 2024 — RaySearch Laboratories AB announced the release of the latest version of RayCare, the next generation ...

Time May 30, 2024
arrow
Subscribe Now